- Home
- NL vs ABEO Comparison
NL vs ABEO Comparison
Compare NL & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NL
- ABEO
- Stock Information
- Founded
- NL 1891
- ABEO 1974
- Country
- NL United States
- ABEO United States
- Employees
- NL N/A
- ABEO N/A
- Industry
- NL Major Chemicals
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- NL Industrials
- ABEO Health Care
- Exchange
- NL Nasdaq
- ABEO Nasdaq
- Market Cap
- NL 320.5M
- ABEO 332.0M
- IPO Year
- NL N/A
- ABEO 1980
- Fundamental
- Price
- NL $6.52
- ABEO $6.83
- Analyst Decision
- NL Sell
- ABEO Strong Buy
- Analyst Count
- NL 1
- ABEO 6
- Target Price
- NL $6.00
- ABEO $18.17
- AVG Volume (30 Days)
- NL 27.5K
- ABEO 702.3K
- Earning Date
- NL 08-06-2025
- ABEO 08-14-2025
- Dividend Yield
- NL 5.50%
- ABEO N/A
- EPS Growth
- NL 141.37
- ABEO N/A
- EPS
- NL 1.10
- ABEO 0.99
- Revenue
- NL $152,721,000.00
- ABEO $400,000.00
- Revenue This Year
- NL $15.75
- ABEO N/A
- Revenue Next Year
- NL $2.44
- ABEO $339.63
- P/E Ratio
- NL $5.96
- ABEO $6.91
- Revenue Growth
- NL N/A
- ABEO N/A
- 52 Week Low
- NL $5.29
- ABEO $3.93
- 52 Week High
- NL $9.42
- ABEO $7.54
- Technical
- Relative Strength Index (RSI)
- NL 51.90
- ABEO 52.71
- Support Level
- NL $6.30
- ABEO $6.70
- Resistance Level
- NL $6.82
- ABEO $7.15
- Average True Range (ATR)
- NL 0.33
- ABEO 0.31
- MACD
- NL 0.04
- ABEO -0.02
- Stochastic Oscillator
- NL 60.00
- ABEO 46.62
About NL NL Industries Inc.
NL Industries Inc is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.